Logo image
Downregulation of NCC and NKCC2 cotransporters by kidney-specific WNK1 revealed by gene disruption and transgenic mouse models
Journal article   Open access   Peer reviewed

Downregulation of NCC and NKCC2 cotransporters by kidney-specific WNK1 revealed by gene disruption and transgenic mouse models

Zhen Liu, Jian Xie, Tao Wu, Thao Truong, Richard J Auchus and Chou-Long Huang
Human molecular genetics, Vol.20(5), pp.855-866
03/01/2011
DOI: 10.1093/hmg/ddq525
PMCID: PMC3033178
PMID: 21131289
url
https://doi.org/10.1093/hmg/ddq525View
Published (Version of record) Open Access

Abstract

WNK1 (with-no-lysine[K]-1) is a protein kinase of which mutations cause a familial hypertension and hyperkalemia syndrome known as pseudohypoaldosteronism type 2 (PHA2). Kidney-specific (KS) WNK1 is an alternatively spliced form of WNK1 kinase missing most of the kinase domain. KS-WNK1 downregulates the Na + -Cl − cotransporter NCC by antagonizing the effect of full-length WNK1 when expressed in Xenopus oocytes. The physiological role of KS-WNK1 in the regulation of NCC and potentially other Na + transporters in vivo is unknown. Here, we report that mice overexpressing KS-WNK1 in the kidney exhibited renal Na + wasting, elevated plasma levels of angiotensin II and aldosterone yet lower blood pressure relative to wild-type littermates. Immunofluorescent staining revealed reduced surface expression of total and phosphorylated NCC and the Na + -K + -2Cl − cotransporter NKCC2 in the distal convoluted tubule and the thick ascending limb of Henle's loop, respectively. Conversely, mice with targeted deletion of exon 4A (the first exon for KS-WNK1) exhibited Na + retention, elevated blood pressure on a high-Na + diet and increased surface expression of total and phosphorylated NCC and NKCC2 in respective nephron segments. Thus, KS-WNK1 is a negative regulator of NCC and NKCC2 in vivo and plays an important role in the control of Na + homeostasis and blood pressure. These results have important implications to the pathogenesis of PHA2 with WNK1 mutations.

Details

Metrics

Logo image